Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer, prostate ...

The following is a summary of “Oncologic outcomes for invasive squamous cell carcinoma with a clinically resolved biopsy site ...

At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its ...

The study did not review oncologic outcomes. Intuitive said previous studies compare perioperative outcomes between these types of surgeries. However, they focused on individual procedures ...

The FDA has approved tislelizumab plus chemotherapy for the treatment of patients with newly diagnosed, locally advanced or ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

The peer-reviewed Annals of Surgery published a meta-analysis of 30-day surgical outcomes across seven oncological surgical procedures, comparing robotic, laparoscopic, and open surgical ...

Another intriguing avenue of research involves combining PNC-27 with emerging cancer agent strategies, such as immunotherapy and gene editing. The peptide's potential to disrupt cancer cell membranes ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no ...

The study took place at an oncology reference center hospital in the Brazilian public health system. The inclusion criteria were subjects who underwent oncologic sternectomy due to palliative or ...

Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...